Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation

American Heart Journal

Volumn 147, Issue 3, 2004, Pages 463-467

  Orford, James L ^a   Fasseas, Panayotis ^a   Melby, Steven ^a   Burger, Kelli ^a   Steinhubl, Steven R ^b   Holmes, David R ^a   Berger, Peter B ^a  

^a MAYO CLINIC   (United States)

^b WILFORD HALL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; WARFARIN; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; DRUG DERIVATIVE; TICLOPIDINE;

AGED; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY STENT; DATA BASE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEART INFARCTION; HOSPITAL PATIENT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIDE EFFECT; THROMBOSIS; CHEMICALLY INDUCED DISORDER; CORONARY ARTERY DISEASE; DRUG COMBINATION; MIDDLE AGED; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY; UNSTABLE ANGINA PECTORIS;

AGED; AGED, 80 AND OVER; ANGINA, UNSTABLE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTICOAGULANTS; ASPIRIN; CORONARY DISEASE; DRUG THERAPY, COMBINATION; FEMALE; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; RETROSPECTIVE STUDIES; STENTS; TICLOPIDINE; WARFARIN;

EID: 2342435108     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ahj.2003.06.004     Document Type: Article

References (11)

1. Popma J.J., Ohman E.M., Weitz J., et al. Antithrombotic therapy in patients undergoing percutaneous coronary intervention. Chest. 119:2001;321-336S
2. Urban P., Macaya C., Rupprecht H.J., et al. Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients the Multicenter Aspirin and Ticlopidine Trial After Intracoronary Stenting (MATTIS). Circulation. 98:1998;2126-2132
3. Schomig A., Neumann F.J., Kastrati A., et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med. 334:1996;1084-1089
4. Leon M.B., Baim D.S., Popma J.J., et al. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators. N Engl J Med. 339:1998;1665-1671
5. Bertrand M.E., Legrand V., Boland J., et al. Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The Full Anticoagulation versus Aspirin and Ticlopidine (FANTASTIC) study. Circulation. 98:1998;1597-1603
6. Bhatt D.L., Bertrand M.E., Berger P.B., et al. Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting. J Am Coll Cardiol. 39:2002;9-14
7. Berger P.B. Results of the Ticlid or Plavix Post-Stents (TOPPS) trial do they justify the switch from ticlopidine to clopidogrel after coronary stent placement? Curr Control Trials Cardiovasc Med. 1:2000;83-87
8. CAPRIE Steering Committee. A randomised, blinded, trial of Clopidogrel versus Aspirin in Patients at Risk of Ischaemic Events (CAPRIE). Lancet. 348:1996;1329-1339
9. Batchelor W.B., Mahaffey K.W., Berger P.B., et al. A randomized, placebo-controlled trial of enoxaparin after high-risk coronary stenting the ATLAST trial. J Am Coll Cardiol. 38:2001;1608-1613
10. Plavix (clopidogrel bisulfate tablets) product insert. Princeton, NJ: Bristol-Myers Squibb Company; 2002
11. Berger P.B., Bell M.R., Hasdai D., et al. Safety and efficacy of ticlopidine for only 2 weeks after successful intracoronary stent placement. Circulation. 99:1999;248-253